Cyprinus carpio Decoction Improves Nutrition and Immunity and Reduces Proteinuria through Nephrin and CD2AP Expressions in Rats with Adriamycin-Induced Nephropathy by Qi, Yumei et al.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 237482, 8 pages
doi:10.1155/2012/237482
Research Article
Cyprinuscarpio Decoction Improves Nutrition and
ImmunityandReducesProteinuriathrough NephrinandCD2AP
Expressionsin Rats with Adriamycin-InducedNephropathy
Yumei Qi,1,2 HuijuanXiao,1,2 ChangjieXu,1,2 XiaojianTian,3,4 Hui Wu,4,5 and Wei Shen4
1Department of Nutrition, Tianjin Third Central Hospital, Tianjin 300170, China
2Tianjin Key Laboratory of Artiﬁcial Cells, Tianjin Third Central Hospital, Tianjin 300170, China
3Department of Nutrition, Second Aﬃliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300000, China
4Institute of Integrative medicine, Qingdao University Medical College, Qingdao 266021, China
5Department of Nutrition, The First Aﬃliated Hospital of Soochow University, Jiangsu, Suzhou 215000, China
Correspondence should be addressed to Yumei Qi, qym0305@yahoo.com.cn
Received 29 November 2011; Revised 3 March 2012; Accepted 19 March 2012
Academic Editor: Cheorl-Ho Kim
Copyright © 2012 Yumei Qi et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cyprinus carpio decoction (CCD) is a well-known Chinese food medicine formula, accepted widely as a useful therapy in
preventing edema and proteinuria caused by renal disease. However, the mechanism underlying this eﬀect remains unclear.
The current study investigated the potential mechanism of CCD in alleviating nephropathy induced by adriamycin (ADR) in
rats. 70 eight-week-old Wistar rats were randomly divided into normal, model, fosinopril, YD, YG groups. All rats except
for the normal group received 6.5mg/kg·bw of ADR injection into the vena caudalis once. Diﬀerent doses of CCD (11.3 and
22.5gkg−1) were lavaged to rats in YD and YG groups, respectively. Then the serum biochemical values of the total protein (TP),
albumin (ALB), blood urea nitrogen (BUN), creatinine (Cr), electrolyte levels, and the urinary protein (UP) content in 12hr
urine were measured. Interleukin-4 (IL-4) and interferon (INF-γ) were measured by enzyme-like immunosorbent assay (ELISA).
The pathomorphological analysis was observed using light and electron microscopy, and the expressions of nephrin and CD2-
associated protein (CD2AP) in renal tissues were determined by immunohistochemical assay. The results indicated that CCD can
relieve ADR-induced nephropathy (ADN) by improving the nutrition status, regulating the immunity, and inhibiting proteinuria
by increasing nephrin and CD2AP expressions.
1.Introduction
The prevalence of chronic kidney disease (CKD) is on
the rise in all ethnic groups. It is a major global issue
with serious harm to human health, characterized by pro-
teinuria, hypoalbuminemia, edema, hypertension, and ab-
normal renal function that progresses to end-stage renal
disease (ESRD) ﬁnally [1]. Adriamycin- (ADR-) induced
nephropathy (ADN) in the rats is usually used for many
studies on the mechanism of various therapies [2, 3]. The
common denominator of this experimental nephropathy,
which mimics minimal-change disease, is a toxin-induced
noninﬂammatory glomerular foot process eﬀacement that
evolves to focal segmental glomerulosclerosis (FSGS) and
tubulointerstitial injury resulting in nephrotic syndrome
(NS) [4]. It was shown that there was a close relationship
between NS and immune dysfunction of T helper cells
(Th): Th1 and Th2 cells. The ﬁndings suggest that the
immune imbalance with dominant Th2 cells, which causes
the abnormal levels of interferon-gamma (INF-γ) mainly
secreted by Th1 cells and interleukin-4 (IL-4) by Th2 cells,
contributes to the glomerular disease through promoting
proteinuria [5]. Proteinuria is one of the important risk
factors, as well as for the performance in the development
of progressive renal disease [6, 7]. It is well established
that podocytes play an important role in maintaining
the integrity of the glomerular ﬁltration barrier [8]. The
discovery and identiﬁcation of nephrin, a transmembrane2 Evidence-Based Complementary and Alternative Medicine
slit diaphragm protein, have improved our understanding
of the molecular mechanisms involved in the maintenance
and function of the glomerular ﬁltration barrier and its role
in the pathogenesis of clinical and experimental proteinuria
[8]. Recently, several additional components of the slit
diaphragm have been identiﬁed, including CD2-associated
protein (CD2AP), which interacts with the cytosolic tail of
nephrin [9]. Disruptions in nephrin and CD2AP have been
identiﬁed as the cause of several inherited and acquired
forms of proteinuria [8, 9].
Cyprinus carpio decoction is a well-known Chinese
food medicine formula. As written in the Compendium of
Materia Medica by Li, it is characterized by sweet and gentle
natureandsurprisingactivitiesofalleviatingwaterretention,
strengthening the spleen, and eliminating dampness, with
channel tropism to spleen, lung, kidney, and liver [10].
Body water metabolism is correlated with the function of
lung, spleen, and kidney in the traditional chinese medicine
(TCM) theory. Based on the theory, it is also believed that
CCD can invigorate the spleen, and replenish lung qi, as
well as regulate water passage [10, 11]. It is a useful therapy
for edema caused by serial diseases, including nephropathy.
It has been extensively used for improving edema, ascites,
pleural eﬀusion induced by nephropathy, liver, cardiac
disease, cancer or pregnancy and polyhydramnios in China
for centuries. It had been ever documented in TCM classics,
for example, the Essential Recipes for Emergent Use Worth
A Thousand Gold written by Simiao Sun in Tang Dynasty
[12], the Medical Secrets of an Oﬃcial by Tao Wang in Tang
Dynasty [13], and the Taiping Prescription of Holy Benev-
olence by Huaiyin Wang in Song Dynasty [14]. In modern
clinical therapy, it is often treated in refractory edema and
receiving unbelievable eﬃcacy. Professor Guan [15]a n dL i
[16] treated nephropathy with severe proteinuria and edema
in a prescription of CCD. They found its alleviating action
was signiﬁcant and it made those symptoms diﬃcult to
recur.However,themechanismisunclearinmodernwestern
medicine. In the nutrition view, Cyprinus is digestible and
rich in protein, microelements and vitamins, for example, A,
B1, C. The ample free amino acid makes it very delicious.
It is a good source of fat acid, myristic acid, palmitic acid,
oleicacid,linoleicacid,andlinolenicacid,especiallyEPAand
DHA. Although almost each component has its function,
such as antioxidation of the decomposed products from the
fresh [17] and vitamins A and C, there is no ﬁnding in which
one or some molecules combined play the role in inducing
diuresis to alleviate edema yet. It is still a mystery and needs
further study.
Although blockade of the rennin-angiotensin-aldostero-
ne system (RAAS), either by angiotensin-converting enzyme
or angiotensin II (AT II) AT-1 receptor blockers, has been
shown to be useful in reducing proteinuria and controlling
renal damage in nephrotic and nonnephrotic renal diseases,
its clinical eﬃcacy is not necessarily satisfactory [18–20].
However, administration of Cyprinus carpio decoction is
increasingly adopted in clinic and civil, which receives
surprising eﬃcacy. Investigations have showed that Cyprinus
carpio decoction has the capacity to prevent urinary protein
in rats with ADN [21, 22]. Our previous work also testiﬁed
thiseﬀect.Nevertheless,littleisknownaboutthemechanism
by which Cyprinus carpio decoction alleviates ADN. There-
fore, we aimed to investigate here how the administration
of Cyprinus carpio decoction could play a protective eﬀect in
rats with ADN.
2. Methods
2.1. Induction of Nephropathy in Wistar Rats. 70 eight-week-
old male Wistar rats (Shandong Lukang Pharmaceutical Co.
Ltd. of China), weighing 160∼200g, were randomly divided
into ﬁve groups: normal group (N, 10 rats), adriamycin-
induced nephrosis model group (M, 15 rats), fosinopril
group (F, 15 rats), and therapeutic groups with low and high
d o s eo fC C D( Y Da n dY G ,1 5r a t si ne a c hg r o u p ) .A l lr a t s
were kept and cared under condition that the temperature
indoor was 23 ± 2◦C and the relative humidity 50∼70. They
were maintained on standard forage and water ad libitum
throughout the experiment. Nephropathy was induced by
administration of adriamycin according to a method pre-
viously described [23] after one-week acclimation. Brieﬂy,
each rat except N group was injected into vena caudlis
with 6.5mg adriamycin (Zhejiang Hisun Pharmaceutical Co.
Ltd., China) kg−1 body weight once. All experiments were
performed in accordance with the NIH’s Guiding Principles
in the Care and Use of Laboratory Animals.
2.2. CCD Preparation. Huanghe common carp, Cyprinus
carpio haematopterus Temminck et Schlegel (Henan Acade-
my of Fishery Science, China), was chose to prepare CCD.
Frozen immediately after harvest and thaw it at room
temperature before preparation. Weigh Cyprinus carpio and
put them into a stainless steel pot after washing them in
cold water three times. Then add to the pot distilled water,
which is four times the weight of the carps. After boiling
10min, stir the mixture and make the ﬂesh of ﬁsh separated
from the bone. Continue heating the mixture gently and
stir it once every 10min until its total weight was four
times as much as that of the ﬁsh, which was about 60min.
Next, close ﬁre and ﬁlter out Cyprinus carpio decoction
(25% concentration) by a 6-drug screen (100 mesh). Make
it condensed to the concentration of 400%, which is 4g
carp per milliliter, with rapid vacuum concentrator (type
5301, Eppendorf China, Ltd.) at 45◦C. Split it and pack
with polyethylene plastic bags at 100mL/bag. Disinfect
them 60min in hot water at 80◦C after sealing. Make
the decoction cool naturally, and store them in −20◦C
refrigerator.
2.3. Products/Drugs Tested Fed to the Treatment Groups of
Rats. Fosinopril is a kind of angiotensin-converting en-
zyme inhibitor, which is commonly used to treat chronic
renal disease. At week 3, rats in fosinopril (Sino-American
Shanghai Squibb Pharmaceuticals Ltd., China) group were
fed as positive control by oral gavage at a dosage of 10mL
fosinopril solution (0.09mg/mL)kg−1 body weight. The
required amount of fosinopril was made up with physiologic
saline and then force-fed to the rats with a strainless steelEvidence-Based Complementary and Alternative Medicine 3
stomachtube.YDandYGgroupwerefedviaoralgavagewith
10mL CCD kg−1 body weight at 1.13g and 2.25g Cyprinus
carpio per milliliter, respectively. Normal and model rats
received an identical volume of vehicle. Normal chow was
provided to all rats. Feeding of fosinopril, CCD, and vehicle
were discontinued after the experimental period of nine
weeks.
2.4.Common ConditionMonitoring. During theexperiment,
record the weight each week and chow consumption each
day.
2.5. Serum, Urine, and Kidney Tissue Samples Preparation.
At the end of each week, 12hr urine samples were obtained
from each rat. When the experiment was over, obtain
serum samples from rats. Then, all rats were sacriﬁced
under general anesthesia using i.p. injection of chloral
hydrate. Kidneys were removed immediately for histological
examinations.
2.6. Clinical Parameter Measurement. Serum levels of total
p r o t e i n( T P ) ,a l b u m i n( A L B ) ,u r e an i t r o g e n( B U N ) ,c r e a t i -
nine (Cr), sodium, potassium, and chloride were determined
withcommerciallyavailablekits(NingboRuiBio-technology
Co., Ltd., China). Urinary protein (UP) excretion in 12hr
was also detected with a commercial kits (Leadman Group
Co., Ltd., China). These serum and urine parameters were
measured by automatic biochemistry analyzer (Olympus
AU640, Olympus Optical Co., Ltd., Japan).
2.7. ELISA Assay for Cytokines. Interleukin-4 (IL-4) and
interferon (INF-γ) were measured by enzyme-liked immun-
osorbent assay (ELISA) (RT-6000, Rayto, USA) as described
in the user’s manual.
2.8. Morphometric Analysis. Kidney sections were ﬁxed in
10% neutral-buﬀered formalin, blocked in paraﬃnw a x ,a n d
stained with hematoxylin-eosin (H&E) for light microscopic
analysis.Forelectronmicroscopy,smallblocksofthekidneys
were ﬁxed in 4% glutaraldehyde, postﬁxed in 2% osmium
tetroxide, dehydrated in graded ethanol, and then embedded
in epoxy resin. Ultrathin sections were stained with uranyl
acetate and lead citrate.
2.9. Immunohistochemical Assay. For immunohistochemical
analysis of CD2-associated protein (CD2AP) and nephrin,
kidney sections were ﬁxed in 4% paraformaldehyde, embed-
ded,andslicedroutinely.Thesections(4μm)wereimmersed
in citrate buﬀer solution (0.01M, pH 6.0) and heated at
120◦C in autoclaved sterilizer for 10min, naturally cooled
for 30min, and then immersed in 3% aqueous hydrogen
peroxide (H2O2) for endogenous peroxidase ablation at
room temperature for 30min. The following steps were
executed in a moist chamber according to the procedure
described in the manual of kits, CD2AP and nephrin
antibody (Beijing Biosynthesis Biotechnology Co., LTD,
China). Finally, the tissue sections were counterstained with
hematoxylin, dehydrated, cleared, and mounted with neutral
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Figure 1: Diet consumption (DC) in the ﬁve groups. All values are
expressed in mean ± SD.
gums. In parallel, tissue specimens in which the primary
antibody was replaced by PBS served as negative control.
Speciﬁcity was established by demonstrating the loss of
immunoreactivity in matched tissue sections. The positive
signal of CD2AP and nephrin proteins was brown or yellow
granular mass that could be used to trace and measure
the aforementioned proteins. The positive signals of these
proteins weremeasuredby twopathologists using Image-Pro
Plus version 6.0 Image Analysis System (Media Cybernetics,
Inc., USA). Five ﬁelds with more than 10 glomeruli in each
ﬁelds per section were chosen randomly and analyzed. The
averageopticaldensity(AOD)whichrepresentedthepositive
staining intensity was calculated as the ratio between the
integratedopticaldensityandthesumareawithpositivecells
in analyzed ﬁelds.
2.10. Statistical Analyses. All data are presented as means
± SD. Repeated measures ANOVA and one-way ANOVA
analysis were performed for comparison in diﬀerent groups
by using SPSS 17.0 software. Diﬀerences were considered
signiﬁcant when P values were <0.05.
3. Results
3.1. Diet Consumption and Rats Weight. At week 3, rats in
YD and YG groups eat 8 and 9g diet per day, respectively.
It was more than M and F groups (5g) (P<0.05). The
consumption gradually increased in every group from week
1t ow e e k5 .H o w e v e r ,t h e r ew a sn od i ﬀerence in each rat
(P>0.05) afterwards (see Figure 1). They ate about 20g
chow one day. Rats grew with time. At the end of the
third week, the weights of rats in the experimental groups
were 0.230±0.029,0.225±0.027,0.252±0.045,and 0.249±
0.017kg. They began lower than normal group (0.328 ±
0.023kg) (P<0.05). At the next week, it was occurred
that signiﬁcant diﬀerences existed during four experimental
groups (P<0.05). However, there was no statistically diﬀer-
ences between YD and YG groups (P>0.05), as shown in
Figure 2.4 Evidence-Based Complementary and Alternative Medicine
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Figure2:Weightintheﬁvegroups.Allvaluesareexpressedinmean
± SD.
3.2. Light Microscopic Observation. It showed that, in the
rat kidney of M group, there were obvious pathological
lesions characterized by glomerular swelling, stenosis of the
r e n a lg l o m e r u l u sc a p s u l a rs p a c e ,b l u r r ym a r g i nb e t w e e n
each part, many inﬂammatory cells around glomerulus, and
abundant protein exudation in the renal tubular lumen
(Figure 3(b1)). In the rats’ kidney of F, YD, and YG groups,
these pathological damages were lighter than those of M
group, although glomerular swelling, inﬂammatory cells
around glomerulus, and protein cast in the renal tubular
lumen were also sporadically observed. The severity of
pathological damage was reduced (Figures 3(c1), 3(d1), and
3(e1)). No pathological changes were found in the kidney of
control group (Figure 3(a1)).
3.3. Electron Microscopy Observation. The ultrastructural
changes of rat kidney in the ﬁve groups were comparatively
analyzed by electron microscopy. In control group, there
were no apparent damages as judged by intactness of renal
glomerulus of rats’ kidney tissue. Clear foot process was
observedonthevisceralsurfaceofrenalglomerularepithelial
cells, which was no swelling, hypertrophy, and inﬂammatory
cells around them (Figure 3(a2)). In M group, the basal
structure of renal glomerulus was damaged. Foot process
diﬀusely changed, became thin and ﬂat, and fused, even
disappeared. The line of glomerular basement membrane
(GBM) was unclear, and there were a lot of inﬂammatory
cells in renal interstitial cells (Figure 3(b2)). In F, YD, and YG
groups, the lesions were signiﬁcantly relieved, although foot
process eﬀacement and inﬂammatory cells were observed in
the renal glomerulus (Figures 3(c2), 3(d2), and 3(e2)). There
was no diﬀerence in electron microscopic morphology in
these three groups.
3.4.ClinicalParameters. AsshowninTable 1,administration
of high dose of CCD signiﬁcantly prevented the decrease in
serum albumin and total protein (P<0.05, versus group M).
There was no signiﬁcant diﬀerence in serum BUN, Cr, Na+,
K+,a n dC l − concentration among each group (P>0.05).
At the third week after induction, the rats excreted plenty of
proteininurine,76.78±8.63,69.66±15.29,77.49±12.83,and
88.25±15.05mg. Urinary protein excretion in 12hr urine of
the rats received fosinopril, and CCD was greatly decreased
(P<0.05), compared with ADN rats, although it was higher
than that of the normal rats (P<0.05).
3.5. Cytokine Level. As shown in Figure 5, CCD can increase
the amount of INF-γ production, although the diﬀerence
was not statistically signiﬁcant. The level of IL-4 in model
group (32.13 ± 2.84pg/mL) was greatly higher than that in
normalgroup(12.55±1.21pg/mL).FosinoprilandCCDcan
dramaticallydecreasethelevelofIL-4,whencomparedtothe
model group. However, there was no signiﬁcant diﬀerence
among groups F, YD, and YG. It was shown that CCD was as
eﬀective as the fosinopril.
3.6. Nephrin and CD2AP Expression. Brown or yellow gran-
ular mass, in a continuous shape of thick line, was found in
the glomerular capillary wall, the attachment of podocytes,
in each group. The expressions of nephrin and CD2AP in
renal tissues of ADNs were decreased with comparison of
that in normal group, especially the model group the lowest.
Its positive expressive area was distributed in punctuation
or irregular clumps. In the rats received Fosinopril and
CCD, the area distribution was more than that in group
M( Figure 6). Semiquantitative analysis of staining inten-
sity showed that the expressions of nephrin and CD2AP
decreased in groups M, F, YD, and YG, compared with the
normal group. However, it had some degree increase in the
three treatment groups (P<0.05, versus group M). See
Figure 7.
4. Discussion
Protein-energy malnutrition (PEM) is common in patients
with chronic kidney disease (CKD) and worsens as the CKD
progresses toward the end-stage renal disease (ESRD). This
condition is one of major predictors of poor clinical out-
come in kidney failure. The data suggested that improving
nutritional statusmayhaveabetter impactonoverallhealth-
related quality of life in CKD [24, 25]. In our study, food
consumption and body weight were dramatically decreased
in the rats of AND from the third to the ﬁfth week. It may be
caused by metabolic changes of protein in tissue and plasma
with anabolism increase and catabolism reduction [26].
Malnutrition in nephropathy made the rats eat less forage
duetobadappetite,whichfurtheraggravatedtheweightloss.
CCD is a well-known traditional Chinese medicine formula
made up of Cyprinus carpio, a kind of ﬁsh, which is rich
in protein and microelements and can be cooked to be a
delicious food. Rats in groups YD and YG that received CCD
ate more food than the model rats and those treated with
fosinopril from the third week to the ﬁfth week, although
all rats had similar consumption at the end of experiment.
Consequently,itpreventedtheweightreduction.Inaddition,
administrationofthisfoodmedicinealsoenhancedthelevels
of total protein and albumin. It may be the result of proteinEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Histopathological analysis of rats’ kidney sections by light microscopy (Row 1) and electron microscopy (Row 2). (a) Normal
group (N), (b) model group (M), (c) fosinopril group (F), (d) YD group (YD), and (e) YG group (YG). Magniﬁcation, ×400.
Table 1: Changes in serum parameters in the ﬁve groups.
Group TP (g/L) Alb (g/L) BUN (mmol/L) Cr (μmol/L) Na+(mmol/L) K+(mmol/L) Cl−(mmol/L)
Group N 68.29 ±4.29 23.18 ±0.97 0.09 ±0.01 79.43 ±7.51 146.00 ± 1.41 6.25 ±1.45 102.10 ±0.99
Group M 59.37 ± 6.28 11.13 ± 2.05 0.16 ± 0.07 73.99 ±7.81 147.67 ± 1.63 6.62 ±0.93 102.17 ±4.40
Group F 66.51 ±7.76∗ 12.74 ± 3.83 0.12 ±0.03 75.06 ±13.44 143.57 ± 3.51 8.08 ± 0.90∗ 100.43 ±2.94
Group YD 67.10 ±4.79∗ 14.18 ± 4.00 0.12 ±0.04 77.55 ±11.13 147.13 ± 4.64 7.66 ± 1.84 101.38 ±3.20
Group YG 68.95 ±4.97∗ 16.45 ± 3.99∗ 0.10 ±0.03 83.43 ±11.14 151.50 ± 2.07∗ 6.92 ±0.55 105.38 ± 3.62
TP, total protein; Alb, albumin; BUN, blood urea nitrogen; Cr, creatinine; Na+,s o d i u mi o n ;K +, potassium ion; Cl−, chloride ion. All values are expressed in
mean ± SD. P < 0.05 versus group N, ∗P<0.05 versus group M, P < 0.05 versus group F.
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Figure 4: Urinary protein (UP) excretion in 12hr urine in the
ﬁve groups. All values are expressed in mean ± SD. At the end
of experiment, UP is 12.42 ± 4.63mg in the normal group (N),
204.15 ± 48.84mg in the model group (M), 121.16 ± 32.80mg in
fosinopril group, 122.29±15.00 in the group with low dose of CCD
(YD), and 144.25 ± 16.65mg in the group with high dose of CCD
(YG). The latter three groups had less UP than the model group.
However, there was no diﬀerence among them.
anabolism enhancement and proteinuria reduction induced
by CCD. These ﬁndings suggest that CCD can improve
anorexia and malnutrition induced by nephropathy.
Several immunological abnormalities have been asso-
ciated with NS, especially helper T lymphocyte function.
There are two kinds of helper T cells; one is T helper-1
(Th1) lymphocyte, secreting primarily INF-γ. The other is
T helper-2 (Th2), producing mainly IL-4. The activity of
Th1 and Th2 cells was deﬁned by the production of INF-
γ and IL-4. Their serum concentration change can reﬂect
the immunity balance status [27, 28]. It was demonstrated
in several studies that INF-γ played a toxic eﬀect on kidney
by breaking up intercellular tight junction of glomerular vis-
ceral epithelial cells and promoting foot process eﬀacement
[27, 29]. However, there is no consensus concerning the
production of INF-γ in patients with NS. Wang et al. [30]
reported that the INF-γ level in the active stage of NS was
signiﬁcantly greater in comparison with normal children,
and it decreased in remission stage. But Stachowski et al.
[31] reported that it was lower in children with NS and
grew up to the level of healthy children in the remission. In
this study, there was no diﬀerence in INF-γ level among the
ﬁve groups. It may be associated with the remission at the
end of experiment, when the serum samples were prepared.
The toxicity of IL-4 on kidney had been described in
previous experiments [27, 32]. It induced adhesion molecule
expression by combining with IL-4 receptor in glomerular
visceral epithelial cells and directly aﬀected the cell structure
and permeability, leading to proteinuria. It was tested that6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: levels of serum interferon-gamma (INF-γ, (a)) and interleukin-4 (IL-4, (b)). Data are shown as means ± SD. P < 0.05 versus
group N,
∗P < 0.05 versus group M.
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Figure 6: Expression of CD2AP (Row 1) and nephrin (Row 2) in each group. (a) Normal group (N), (b) model group (M), (c) fosinopril
group (F), (d) YD group (YD), and (e) YG group (YG). Magniﬁcation, ×400.
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Figure 7: The average optical density (AOD) of CD2AP (a) and nephrin (b) expression in rats’ kidneys in the ﬁve groups. Data are shown
as means ± SD. P < 0.05 versus group N,
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there was a positive correlation between IL-4 and urinary
protein [32]. We observed that rats administered with CCD
produced less IL-4 than those in ADN. The eﬀect was the
same with fosinopril. It may be indicated that CCD can
reverse the immune imbalance with dominant Th2 cells by
reducing the secretion of IL-4 and improve the immune
function, which is helpful to relieve ADN.
Proteinuria is an important risk factor for the pro-
gression and prognosis of chronic renal disease [33, 34].
Therefore, the pathophysiologic mechanisms underlying its
development and improvement under several therapies are
focusedon by many researchers[35–39]. Theslit diaphragm,
bridging the space between adjacent foot processes, was
assumed to make an important contribution to the molecu-
lar sieve for glomerular ﬁltration. Recently, increased insight
in the molecular makeup of the podocyte foot processes
and slit diaphragm, including nephrin and CD2AP, led to
the support for the pivotal role of these structures in the
maintenance of permselectivity [35, 36].
Nephrin is a member of the immunoglobulin super-
family of transmembrane cell adhesion molecules [37]. It
is localized to the slit pore of podocytes and contributes to
the integrity of the SD. Several investigators have examined
the integrity of the slit diaphragm in acquired proteinuric
diseases, using the slit diaphragm protein nephrin as a
marker. It had been reported that there was no nephrin and
SD disappeared under electron microscopy in the patients
with inherited nephrotic syndrome [38]. It has been recently
found that nephrin expression level is reduced in experi-
mental animal models and human-acquired renal disease
withproteinuria[39,40].Nephringeneknock-outmicedied
of severe proteinuria shortly after birth. Benigni et al. [41]
reported that the glomeruli of rats with massive proteinuria
showed a progressive decline in nephrin mRNA and protein
content from 1wk to 8 mo after disease induction. These
studies suggest that nephrin may play an important role in
the development of proteinuria.
CD2AP is expressed primarily in glomerular podocytes
at the cytoplasmic face of the SD domain where it interacts
with nephrin and podocin [9, 42]. Lack of the glomerular
expression of CD2AP in animals produces mesangial cell
proliferation with extracellular matrix deposition, glomeru-
losclerosis, and extensive foot-process eﬀacements [43] that
are correlated with the entity of the defect. Shih et al. [43]
reported that mice with CD2AP gene knockout died of
renal failure progressed from massive proteinuria shortly
after birth and observed the damaged podocytes and foot
process fusion and eﬀacement, like the pathological change
in nephrotic syndrome. Intervening on CD2AP may be the
pathophysiological basis developing the proteinuria in renal
disease. In our study, proteinuria relieved after using CCD
in the rats with ADN, as well as glomeruli inﬂammation
and foot process eﬀacement reduced. It can be explained by
the increment of nephrin and CD2AP expression. Thus, it
is established that nephrin and CD2AP are critical in main-
taining the integrity of the slit diaphragm and preventing
proteinuria.
In conclusion, the present study shows that CCD
has a protective eﬀect against ADR-induced nephropathy,
and this eﬀect may be attributed to the improvement of
nutrition status and regulation of cytokines and immune
balance. Moreover, the roles of CCD are related to the
reduction of proteinuria through promoting nephrin and
CD2AP expressions. The ﬁndings may shed light on the
pharmacological basis for the clinical application of the tra-
ditionalChinesemedicineinthetreatmentofchronickidney
disease. However, which materials play the pharmacological
activities, some free amino acids rich in CCD or others? It
is still unclear. Thus, it needs further study on the acting
compounds of CCD.
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